These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 7089464

  • 21. [Desensitization with allergens: early, specific, effective therapy of immune system almost without side effects. Interview by Dr. Barbara Scholtissek].
    Fiebig H, Kahlert H.
    Wien Med Wochenschr; 1999; 149(14-15):447, 449-50. PubMed ID: 10584292
    [No Abstract] [Full Text] [Related]

  • 22. [Long-term tolerance of specific hyposensitization with the aid of calcium phosphate-adsorbed mite extracts].
    Lelong M, Miersman R.
    Allerg Immunol (Paris); 1986 Nov; 18(9):15-6, 18. PubMed ID: 2456078
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Immunological mechanism of desensitization treatment of atopic diseases].
    Kujawa H.
    Postepy Hig Med Dosw; 1980 Nov; 34(4):321-38. PubMed ID: 6170055
    [No Abstract] [Full Text] [Related]

  • 26. Toll-like receptors as targets for enhancing the efficacy of immunotherapy.
    Mutschlechner S, Deifl S, Bohle B.
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009 Nov; 96():296-301; discussion 301-2. PubMed ID: 20799474
    [No Abstract] [Full Text] [Related]

  • 27. [Practical problems in specific hyposensitization].
    Oehling A.
    Med Klin; 1972 Jul 21; 67(29):983-8. PubMed ID: 5051382
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Update on sublingual immunotherapy treatment regimes.
    Spangfort MD.
    Eur Ann Allergy Clin Immunol; 2006 Sep 21; 38(7):244. PubMed ID: 17124783
    [No Abstract] [Full Text] [Related]

  • 31. [Recommendations for hyposensitization with allergen extracts. Medical Society of German Allergologists].
    Sennekamp J, Kersten W, Fuchs E, Hornung B.
    Med Monatsschr Pharm; 1989 Oct 21; 12(10):315-8. PubMed ID: 2682154
    [No Abstract] [Full Text] [Related]

  • 32. Mold allergy--clinical use of emulsified mold allergens.
    Prince HE.
    J Kans Med Soc; 1968 Oct 21; 69(10):464-5. PubMed ID: 5705534
    [No Abstract] [Full Text] [Related]

  • 33. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
    Valenta R, Vrtala S, Focke-Tejkl M, Twardosz A, Swoboda I, Bugajska-Schretter A, Spitzauer S, Kraft D.
    Clin Allergy Immunol; 2002 Oct 21; 16():495-517. PubMed ID: 11577556
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Risks of specific hyposensitization treatment].
    Rakoski J.
    Z Hautkr; 1988 Oct 21; 63 Suppl 4():26-30. PubMed ID: 3075381
    [Abstract] [Full Text] [Related]

  • 36. [New concepts in therapy of type I allergic diseases].
    Valenta R, Steinberger P, Vrtala S, Grote M, Laffer S, Sperr WR, Valent P, Kraft D, Scheiner O.
    Wien Klin Wochenschr; 1993 Oct 21; 105(23):682-6. PubMed ID: 7508663
    [Abstract] [Full Text] [Related]

  • 37. [Allergen-specific immunotherapy--vaccination against allergy].
    Brygge T, Mosbech H.
    Ugeskr Laeger; 2000 Jan 24; 162(4):524-7. PubMed ID: 10697458
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. How to stop the allergy march.
    Lopes Dos Santos JM.
    Int J Immunopathol Pharmacol; 2005 Jan 24; 18(4 Suppl):39-40. PubMed ID: 17761107
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.